Gabapin NT 100 Tablet: Benefits and Uses, Side Effects

Information about Gabapin NT 100 Tablet

Gabapin NT 100 Tablet is manufactured by Intas Pharmaceuticals Ltd. It is used to treat neuropathic pain, diabetes, long-lasting (chronic) pain due to nerve damage due to spinal cord injury. It reduces pain and associated symptoms such as mood swings, sleep problems, and fatigue.

Gabapin NT 100 Tablet Composition

Gabapentin (100mg) + Nortriptyline (10mg)

Gabapentin is an alpha 2 delta ligand that reduces pain by modulating the calcium channel activity of nerve cells.

Nortriptyline is a tricyclic antidepressant that increases the levels of chemical messengers (serotonin and noradrenaline) that inhibit the movement of pain signals in the brain. Which relieves neuropathic pain (pain from damaged nerves).

Gabapin NT 100 Tablet benefits and uses

Gabapin NT 100 Tablet is used for the prevention and treatment of the following diseases –

Nerve pain

Neuropathic pain

Depression

Gabapin NT 100 Tablet Dosage

Dosage:- Take one tablet once a day or as directed by the doctor. Swallow it whole. Do not chew, crush or break it. Gabapin NT 100 Tablet can be taken before or after a meal.

Gabapin NT 100 Tablet Side Effects

If your symptoms do not improve after taking it. Or if your condition worsens, consult your doctor immediately.

Common side effects are as follows-

Constipation

difficulty urinating

Weight gain

Lethargy

Dizziness

Fatigue

Blurred vision

Dry mouth

Orthostatic hypotension (sudden drop in blood pressure on standing)

Heart rate increase

Apart from the above-mentioned side effects, some other side effects can also occur. If you notice any unusual symptoms while using the medicine, contact the doctor immediately.

Precautions-

Use its dosage as per the instructions given by the doctor.

Do not exceed the recommended dose.

Read the label carefully before use

Keep away from sunlight, in a cool and dry place.

Keep the medicine away from children and pets.

Leave a Comment

Your email address will not be published. Required fields are marked *